1. Cerebrospinal fluid pharmacokinetics and penetration of continuous infusion topotecan in children with central nervous system tumors

   • Sharyn D. Baker
   • Richard L. Heideman
   • Clinton F. Stewart

   Topotecan, CSF Penetration, CSF Pharmacokinetics Pages: 195 - 202

2. A microcomputer program for calculating cell population doubling time in vitro and in vivo

   • Jeffrey I. Zwicker
   • Robert T. Proffitt
   • C. Patrick Reynolds

   Cell Growth Kinetics, Nude Mice, Microcomputer, Computer Software Pages: 203 - 210

3. Antitumor activity of treosulfan in human lung carcinomas

   • P. Köpf-Maier
   • G. Saß

   Treosulfan, Alkylating Agent, Antitumor Activity, Small-Cell Lung Carcinomas, Non-Small-Cell Lung Carcinomas Pages: 211 - 221

4. Schedule-dependent synergism of taxol or taxotere with edatrexate against human breast cancer cells in vitro

   • Ting-Chao Chou
   • Glenys M. Otter
   • Francis M. Sirotnak

   Edatrexate, Taxol, Taxotere, Breast Cancer, Combination Treatment Pages: 222 - 228

5. Phase I trial of fluorouracil modulation by N-phosphonacetyl-L-aspartate and 6-methylmercaptopurine ribonucleoside

   • Alxandre Hageboutros
   • Gary R. Hudes
   • Peter J. O'Dwyer

   5-Fluorouracil, Phosphonacetyl-L-Aspartate, b-Methylmercaptopurine Riboside, Combination Treatment, Pharmacokinetics Pages: 229 - 234

6. Multi-chemothermoimmunotherapy for human colon adenocarcinoma in vitro

   • Jim Klostergaard
   • M. Elena Leroux
   • Stephen P. Tomasovi

   Chemotherapy, TNF, Hyperthermia, Colon Adenocarcinoma, Multimodality Pages: 235 - 241

7. Repair analysis of 4-hydroperoxycyclophosphamide-induced DNA interstrand crosslinking in the c-myc gene in 4-hydroperoxycyclophosphamide-sensitive and-resistant medulloblastoma cell lines

   • Qing Dong
   • Nancy Bullock
   • Henry S. Friedman

   4-Hydroperoxycyclophosphamide, c-myc, DNA Interstrand Crosslinks Pages: 242 - 246

8. Busulfan disposition and hepatic veno-occlusive disease in children undergoing bone marrow transplantation

   • Gilles Vassal
   • Serge Koscielny
   • Olivier Hartmann

   Busulfan, Pharmacodynamics, Hepatic Veno-Occlusive Disease Pages: 247 - 253

9. Phase I-II study: triciribine (tricyclic nucleoside phosphate) for metastatic breast cancer

   • Karen Hoffman
   • Frankie Ann Holmes
   • Gabriel N. Hortobagyi

   Tricyclic Nucleoside, Phosphate, Triciribine, Metastatic Breast Cancer, Hypertriglyceridemia, Hyperglycemia Pages: 254 - 258

10. 5-fluorouracil metabolism and cytotoxicity after pre-treatment with methotrexate or thymidine in human hypopharynx and colon carcinoma xenografts: a¹⁹F-nuclear magnetic resonance spectroscopy study in vivo

    • Robert Tausch-Treml
    • Frank Baumgart
    • Petra Köpf-Maier

    19F-NMR Spectroscopy, 5-FU, Combined Treatment Modality Pages: 259 - 265

11. Evaluation of formulas using the serum creatinine level to calculate the optimal dosage of carboplatin

    • Laurence J. C. van Warmerdam
    • Sjoerd Rodenhuis
    • Jos H. Beijnen

    AUC, Carboplatin, Pharmacokinetics Pages: 266 - 270

12. Comparison of the antitumor activity of bryostatins 1, 5, and 8

    • Andrew S. Kraft
    • Steven Woodley
    • Fred Wagner

    Bryostatin Analogs, Protein Kinase C, Tumor Necrosis Factor, Bryostatin Blood Levels Pages: 271 - 278

13. Comparison of the efficacy of tropisetron versus a metoclopramide cocktail based on the intensity of cisplatin-induced emesis

    • Ting-Chang Chang
    • Fushing Hsieh
    • Yoong-Kuei Soong

    Tropisetron, Metoclopramide Cocktail, Cisplatin-Induced Emesis Pages: 279 - 285

14. Effect of different mathematical methods on etoposide area under the curve estimations and pharmacodynamic response predictions

    • Dayna L. McCauley
    • Bert L. Lum
    • Branimir I. Sikic

    Etoposide, Pharmacokinetics, AUC Pages: 286 - 288